CW Advisors LLC Acquires 10,671 Shares of Axon Enterprise, Inc $AXON

Key Points

• CW Advisors LLC increased its holdings in Axon Enterprise, Inc by 1,371.6%, owning a total of 11,449 shares valued at $6.02 million as of the latest SEC filing.
• Recently, several institutional investors have also adjusted their positions in Axon, with institutional ownership of the company now at 79.08%.
• In the last quarter, Axon reported an earnings per share (EPS) of $2.12, exceeding analyst expectations by $0.58, with revenue growing 32.6% year-over-year.

CW Advisors LLC lifted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 1,371.6% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,449 shares of the biotechnology company's stock after purchasing an additional 10,671 shares during the period. CW Advisors LLC's holdings in Axon Enterprise were worth $6,022,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Brighton Jones LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $480,000. NewEdge Advisors LLC grew its holdings in shares of Axon Enterprise by 13.4% during the fourth quarter. NewEdge Advisors LLC now owns 1,626 shares of the biotechnology company's stock valued at $966,000 after purchasing an additional 192 shares during the last quarter. OneDigital Investment Advisors LLC grew its holdings in shares of Axon Enterprise by 22.3% during the fourth quarter. OneDigital Investment Advisors LLC now owns 2,510 shares of the biotechnology company's stock valued at $1,492,000 after purchasing an additional 457 shares during the last quarter. Hancock Whitney Corp bought a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $234,000. Finally, Kovitz Investment Group Partners LLC grew its holdings in shares of Axon Enterprise by 31.7% during the fourth quarter. Kovitz Investment Group Partners LLC now owns 1,081 shares of the biotechnology company's stock valued at $642,000 after purchasing an additional 260 shares during the last quarter. Institutional investors own 79.08% of the company's stock.

Analysts Set New Price Targets

AXON has been the topic of a number of recent analyst reports. Raymond James Financial reaffirmed an "outperform" rating and set a $855.00 price target (up previously from $645.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Bank of America lifted their price target on Axon Enterprise from $895.00 to $1,000.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Morgan Stanley set a $885.00 price target on Axon Enterprise and gave the company an "overweight" rating in a report on Friday, July 11th. UBS Group reaffirmed a "neutral" rating and set a $840.00 price target (up previously from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Finally, JPMorgan Chase & Co. boosted their target price on Axon Enterprise from $730.00 to $850.00 and gave the stock an "overweight" rating in a report on Thursday, July 17th. Thirteen analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $837.69.

Axon Enterprise Stock Up 0.1%

Shares of AXON stock traded up $0.66 on Wednesday, hitting $769.68. The company's stock had a trading volume of 326,541 shares, compared to its average volume of 698,928. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. Axon Enterprise, Inc has a fifty-two week low of $346.71 and a fifty-two week high of $885.91. The firm's fifty day moving average price is $772.54 and its 200-day moving average price is $675.22. The stock has a market capitalization of $60.42 billion, a price-to-earnings ratio of 190.04, a P/E/G ratio of 28.02 and a beta of 1.36.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The business had revenue of $668.54 million during the quarter, compared to analyst estimates of $641.77 million. During the same quarter in the previous year, the business earned $1.20 EPS. Axon Enterprise's quarterly revenue was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. Research analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Insiders Place Their Bets

In other Axon Enterprise news, President Joshua Isner sold 15,919 shares of the business's stock in a transaction on Friday, August 15th. The shares were sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the completion of the transaction, the president owned 238,379 shares of the company's stock, valued at $177,892,712.54. The trade was a 6.26% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jeffrey C. Kunins sold 7,891 shares of the business's stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the transaction, the insider directly owned 144,538 shares of the company's stock, valued at approximately $108,417,953.80. This represents a 5.18% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 43,790 shares of company stock worth $33,654,451 in the last 90 days. 5.70% of the stock is owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.